Home |  News |  Events |  Publications |  Contact 
Corporate Investor LifeScience Diagnostics Commercial Technology Career
 
Corporate
 11News
News  
Announcements


ANNOUNCEMENTS - Investor
Appointment of Jeremy Davis as Chairman
GRADIPORE APPOINTS JEREMY DAVIS CHAIRMAN OF THE BOARD --Seasoned Business Executive Brings Over 30 years of Management Experience-- SYDNEY (September 23, 2002) Gradipore, a global biotechnology company (ASX Code: GDP) today announced the appointment of Jeremy Guy A. Davis, MBA to Chairman of the Board. Mr. Davis has more than 30 years of management experience and is the AMP Society Professor of Management at the Australian Graduate School of Management (AGSM). During his tenure at AGSM, ... [ Find out more ]


 Found 62 results.
Showing page 1  2 3 > 


28/Oct/2002
ANNOUNCEMENTS  -  INVESTOR
Presentation to analysts October 28/29th 2002

03/Oct/2002
ANNOUNCEMENTS  -  INVESTOR
Q&A relating to the Cangene Licensing Deal
Sydney, October 2, 2002 Following the announcement on 11th September 2002 advising that Gradipore and Cangene had signed a licensing agreement for th ...

12/Sep/2002
ANNOUNCEMENTS  -  INVESTOR
2002 Appendix 4B Report
View via attached download link

12/Sep/2002
ANNOUNCEMENTS  -  INVESTOR
Financial Results 2002
Gradipore Reports Increase In Sales Revenue Restructure Positions Company for Strong Revenue Growth SYDNEY (September 12, 2002) Biolo ...

06/Aug/2002
ANNOUNCEMENTS  -  INVESTOR
Texas A&M Update - ASX Announcement
Gradipore (ASX: GDP) has announced that the initial phase of its collaborative work with Texas A&M University, a leading US university, is close to c ...

26/Jun/2002
ANNOUNCEMENTS
Investor presentation by Robert Lieb, CEO, Gradipore Limited, given to investors in Sydney and Melbourne June 26th and June 27th 2002

23/May/2002
ANNOUNCEMENTS  -  INVESTOR
Appointment of New Chief Executive Officer
SYDNEY - Gradipore (ASX Code: GDP) announced today the appointment of Robert Lieb as its global Chief Executive Officer and Vice Chairman of the Compa ...

20/May/2002
ANNOUNCEMENTS  -  INVESTOR
Director's report Appendix 4B Dec 2001
The Director's report of Appendix 4B released to the ASX in March 2002 is a good overview of Gradipore's current strategies and operational performanc ...

19/Apr/2002
ANNOUNCEMENTS  -  INVESTOR
Gradipore to Strengthen Board and Executive Team
Following agreements with organisations including: Bayer Texas A&M University VWR International Inc Scottish National Blood Transfu ...

16/Apr/2002
ANNOUNCEMENTS  -  INVESTOR
Gradipore takes another step in proving its technology for dialysis use
Biological separations company, Gradipore Ltd (ASX: GDP) has successfully completed an important step in a program aimed at proving its technology f ...

14/Mar/2002
ANNOUNCEMENTS  -  INVESTOR
Gradipore Announces Half Yearly Results - Revenue/R&D Both Up
SYDNEY(March 14th, 2002) - Biological separations company, Gradipore Limited, reported a significant increase in sales revenue (75%) which was offset ...

21/Feb/2002
ANNOUNCEMENTS  -  INVESTOR
Gradipore introduces new LongLife precast gradient gels into US$350 Million gel market
NEW YORK (February 21, 2002) Gradipore, a global biotechnology company (ASX Code: GDP) announced today the introduction of a new line of long-life e ...

11/Feb/2002
ANNOUNCEMENTS  -  INVESTOR
Biomira and Gradipore collaborate for separation and purification of recombinant proteins
NEW YORK (February 10, 2002) Gradipore Ltd. (ASX Code: GDP) has entered into an agreement with Biomira Inc. for the separation and purification of r ...

30/Jan/2002
ANNOUNCEMENTS  -  INVESTOR
Gradipore announces United States presence
NEW YORK (January 30, 2002) As part of its focused globalization strategy, Gradipore Inc., (ASX Code: GDP) today announced the opening of a new offi ...

08/Jan/2002
ANNOUNCEMENTS  -  CORPORATE
94.14 % of listed $2.50 options exercised
SYDNEY (January 8, 2002) Gradipore (ASX Code: GDP) announced that 8.65 million listed $2.50 options, representing approximately 94.14% of the total ...

19/Dec/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore and Aventis Behring collaborate to separate and purify immunoglobulin from plasma
NEW YORK (December 19, 2001) Gradipore (ASX Code: GDP) has entered into a research agreement with Aventis Behring L.L.C., a global leader in the the ...

03/Dec/2001
ANNOUNCEMENTS  -  INVESTOR
Underwriting fee for $2.50 listed options
SYDNEY Gradipore (ASX Code: GDP), has announced that a fee of 3.6% is to be paid to the underwriters of the 9.19 million $2.50 share options expir ...

23/Nov/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore announces underwriting agreement for listed options
(Gradipore (ASX Code: GDP) has entered into an underwriting agreement for its listed $2.50 share options which expire on 31 December 2001. Exercis ...

13/Nov/2001
ANNOUNCEMENTS  -  COMMERCIAL SEPARATIONS
Gradipore and Scottish National Blood Transfusion Service collaborate to develop tests for the detection of abnormal prions in the diagnosis of vCJD and mad cow disease, Sydney.
Gradipore (ASX Code: GDP) has entered into a development agreement with the Scottish National Blood Transfusion Service (SNBTS), for the early detecti ...

29/Oct/2001
ANNOUNCEMENTS  -  INVESTOR
Outcome of resolutions at the AGM 29th October 2001
MINUTES OF THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF GRADIPORE LTD HELD AT 10.00AM ON MONDAY 29 OCTOBER 2001 AT THE POWERHOUSE MUSEUM - COLES THEA ...

26/Oct/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore announces formation of Scientific Advisory Board; first two members appointed.
Gradipore (ASX Code: GDP) announced that it has named Dr. John E. Jefferis and Dr. David Silverman as the first two members of its newly-formed Scient ...

26/Sep/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore strengthens worldwide leadership with new Board Member additions
Pivotal Appointments in Key Regions Enhance Global Presence. Gradipore, a global biotechnology company (ASX Code: GDP) appoints two highly recogniz ...

19/Sep/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore and VWR International sign worldwide distribution agreement
Agreement Enhances Availability of Gradipore Laboratory Products in the United States SYDNEY (September 19, 2001) Gradipore, a global biot ...

13/Sep/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore makes strong progress in 2001 Financial year
Biological separations company, Gradipore Limited made strong progress in the 2001 financial year towards its long-term objective of becoming a global ...

29/Aug/2001
ANNOUNCEMENTS  -  INVESTOR
Gradipore signs two distribution agreements and commences gel rollout in Asia
Biotechnology company, Gradipore Limited, has signed two new supply agreements as it commences the rollout in Asia of its scientific gel distribution ...

 

 
Contact Us | Terms of Use | | Terms of Use
2002 Gradipore Limited All rights reserved.